Won't Rush Covid-19 Vaccine, Safety & Quality is Paramount: Bharat Biotech Chairman on Phase I Trials in Top Business News- News18.com published on August 09, 2020 leave a reply Responding to the launch date for the vaccine, Ella added that they want to do clinical research of the highest standards as they are being international agencies and communities. from Top Business News- News18.com https://ift.tt/2DFhn70 Tweet Share Share Share Share Previous Post Asian shares calm as Sino-U.S. tensions flare up Next Post Top U.S. mall operator Simon faces pandemic pain post written by: Rohit Related PostsRupee Falls 20 Paise to 71.76 Against Dollar in Early TradeForeign funds purchased shares worth Rs 694.97 crore on a net basis, and domestic institutional investors bought shares worth Rs 525.26 crore on Wednesday, prov… Continue ReadingRBI's Surprise Rate Cut an Indication of Falling Prices, Likely to Help BJP in ElectionsRBI’s rate cut will bring in further good news for consumers. As a lowered interest rate makes it even more flexible for companies to borrow at a cheaper rate f… Continue ReadingRBI Cuts Lending Rate to 6.25% in First Review Under Shaktikanta Das; Will Banks Pass it On?In the first policy review under Governor Shaktikanta Das, the six-member Monetary Policy Committee voted 4:2 in favour of the rate cut, while the decision to c… Continue ReadingRBI Raises Collateral-free Farm Loan Limit to Rs 1.6 Lakh Days After Cash Handout Announcement in BudgetThe central bank also decided to set up an internal working group (IWG) to review agricultural credit and arrive at a workable policy solution. from Top Busine… Continue ReadingSensex Jumps 150 Points; RBI Committee to Announce Policy Decision SoonSun Pharma, Bajaj Auto, HCL Tech, Tata Motors, M&M, Yes Bank, Maruti and Hero MotoCorp were the top gainers, rising up to 2.64 per cent while shared of the … Continue Reading
0 comments: